Terms: = Prostate cancer AND SRSF3, SRp20, SFRS3, 6428, ENSG00000112081, P84103
5 results:
1. Unveiling hormone-stimulated gene mechanisms in prostate cancer: A prognostic model, immune infiltration analysis, and drug sensitivity study.
Fan Z; Yu Q; Deng J; Wang K; Yu H; Fan X; Xie J
Environ Toxicol; 2024 May; 39(5):3238-3252. PubMed ID: 38361268
[TBL] [Abstract] [Full Text] [Related]
2. Quality of life after non-nerve-sparing, robot-assisted radical prostatectomy.
Nakai Y; Tanaka N; Inoue T; Onishi K; Morizawa Y; Hori S; Gotoh D; Miyake M; Torimoto K; Fujimoto K
Asia Pac J Clin Oncol; 2024 Feb; 20(1):93-100. PubMed ID: 37850378
[TBL] [Abstract] [Full Text] [Related]
3. Establishing a Proteomics-Based Signature of AKR1C3-Related Genes for Predicting the Prognosis of prostate cancer.
Cui X; Li C; Ding J; Yao Z; Zhao T; Guo J; Wang Y; Li J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901944
[TBL] [Abstract] [Full Text] [Related]
4. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer.
Jiménez-Vacas JM; Herrero-Aguayo V; Montero-Hidalgo AJ; Gómez-Gómez E; Fuentes-Fayos AC; León-González AJ; Sáez-Martínez P; Alors-Pérez E; Pedraza-Arévalo S; González-Serrano T; Reyes O; Martínez-López A; Sánchez-Sánchez R; Ventura S; Yubero-Serrano EM; Requena-Tapia MJ; Castaño JP; Gahete MD; Luque RM
EBioMedicine; 2020 Jan; 51():102547. PubMed ID: 31902674
[TBL] [Abstract] [Full Text] [Related]
5. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract] [Full Text] [Related]
